Yousif Capital Management LLC cut its stake in shares of Genpact Limited (NYSE:G – Free Report) by 2.6% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 57,095 shares of the business services provider’s stock after selling 1,546 shares during the period. Yousif Capital Management LLC’s holdings in Genpact were worth $2,513,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of G. GAMMA Investing LLC raised its position in shares of Genpact by 88.0% in the first quarter. GAMMA Investing LLC now owns 9,744 shares of the business services provider’s stock valued at $491,000 after buying an additional 4,561 shares during the last quarter. SG Americas Securities LLC raised its position in shares of Genpact by 83.7% in the first quarter. SG Americas Securities LLC now owns 10,175 shares of the business services provider’s stock valued at $513,000 after buying an additional 4,637 shares during the last quarter. Fifth Third Bancorp raised its position in shares of Genpact by 9.5% in the first quarter. Fifth Third Bancorp now owns 3,461 shares of the business services provider’s stock valued at $174,000 after buying an additional 299 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its position in shares of Genpact by 20.6% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 9,650 shares of the business services provider’s stock valued at $486,000 after buying an additional 1,651 shares during the last quarter. Finally, Ritholtz Wealth Management acquired a new stake in shares of Genpact in the first quarter valued at about $382,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Genpact Trading Up 1.3%
Shares of G stock opened at $39.48 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.53 and a quick ratio of 1.53. The firm has a market cap of $6.88 billion, a PE ratio of 13.11, a price-to-earnings-growth ratio of 1.34 and a beta of 0.89. The company has a 50-day moving average of $42.67 and a two-hundred day moving average of $44.22. Genpact Limited has a 1-year low of $37.82 and a 1-year high of $56.76.
Genpact Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 23rd. Shareholders of record on Tuesday, December 9th will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Tuesday, December 9th. Genpact’s dividend payout ratio (DPR) is 22.59%.
Insider Activity
In other Genpact news, CEO Balkrishan Kalra sold 55,000 shares of the stock in a transaction dated Thursday, September 11th. The shares were sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the completion of the transaction, the chief executive officer owned 295,246 shares of the company’s stock, valued at $12,801,866.56. This trade represents a 15.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Piyush Mehta sold 76,902 shares of the stock in a transaction dated Friday, September 12th. The stock was sold at an average price of $42.58, for a total transaction of $3,274,487.16. Following the transaction, the senior vice president directly owned 134,880 shares of the company’s stock, valued at approximately $5,743,190.40. This trade represents a 36.31% decrease in their position. The disclosure for this sale can be found here. Company insiders own 3.07% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on G. JPMorgan Chase & Co. reduced their target price on shares of Genpact from $55.00 to $50.00 and set a “neutral” rating for the company in a research report on Wednesday, August 20th. Mizuho upped their price objective on shares of Genpact from $48.00 to $51.00 and gave the company a “neutral” rating in a report on Tuesday, July 1st. Needham & Company LLC upped their price objective on shares of Genpact from $50.00 to $53.00 and gave the company a “buy” rating in a report on Friday, August 8th. Deutsche Bank Aktiengesellschaft began coverage on shares of Genpact in a report on Thursday, July 17th. They issued a “hold” rating and a $47.00 price objective for the company. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Genpact in a report on Wednesday, October 8th. Three research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, Genpact presently has an average rating of “Hold” and a consensus target price of $52.29.
Get Our Latest Stock Analysis on Genpact
Genpact Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading
- Five stocks we like better than Genpact
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- This AI Chip Giant Could Be the Market’s Next Big Winner
- How to Invest in Insurance Companies: A Guide
- Broadcom Inks OpenAI Deal: Why It’s A Huge Win for AVGO Stock
- 5 discounted opportunities for dividend growth investors
- Institutions Are Fueling CrowdStrike’s Next Leg Higher
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.